Korean aesthetic medicine is having a moment. The trend spans treatments from skin boosters to HIFU, radiofrequency, lasers, and non-surgical body contouring. Patients and influencers are traveling to Seoul to access many of these treatments, while British Vogue and other media have helped bring growing attention to Korean aesthetics in North America.
Importantly, the technologies behind several of those treatments are available here. Patients don’t need to book a flight to access them, and providers don’t need to watch that demand leave the practice.
Here are some of the technologies helping shape the trend, what each one addresses clinically, and where they can be sourced in the United States and Canada.
The attention around Korean aesthetics is backed by substantial and growing domestic adoption. South Korea’s aesthetic devices market was valued at $567.8M in 2026 and is projected to reach $838.6M by 2031, an 8.11% CAGR, according to Mordor Intelligence.
That influence is increasingly visible in the rise of aesthetic tourism. Influencers, beauty editors, and other beauty enthusiasts are traveling to Seoul specifically for treatments, often visiting multiple clinics and documenting the experience for audiences back home. Concierge services have even emerged to help international visitors navigate the process, from identifying clinics and coordinating appointments to arranging translation and building treatment itineraries.
For those who can make the trip, it’s a chance to experience treatments in one of the world’s most influential aesthetics markets. But that experience isn’t accessible to most patients, and the content surrounding these trips still shapes what patients see, ask about, and want closer to home, underscoring Cartessa’s leading role in bringing differentiated global aesthetic technologies to North American practices.
Premier aesthetic device manufacturer CLASSYS offers one example. Its Shurink Universe has built a strong presence in Korea’s HIFU market, while its international counterpart, Ultraformer MPT, has expanded globally with a particularly strong presence in Eurasia and Latin America. Today, CLASSYS markets its portfolio across more than 80 countries. (For a fuller look at how that ecosystem developed, see why Seoul became the global capital of medical aesthetics.)
The treatments gaining attention in Korea span a range of aesthetic goals, from non-surgical lifting and skin tightening to improvements in texture, tone, and body contouring. What links many of them is not a single treatment philosophy, but the use of energy-based technologies and combination approaches designed to address different concerns with limited downtime.
That can include HIFU for lifting and tightening, radiofrequency-based treatments for skin quality and firmness, and other noninvasive modalities for contouring and tissue remodeling. The result is a treatment landscape shaped as much by how technologies are combined and applied as by the individual devices themselves.
Among the technologies helping address that range of aesthetic goals are four state-of-the-art platforms with distinct approaches and applications.
EVERESSE, marketed outside North America as Volnewmer®, was designed to address several practical limitations associated with existing monopolar RF platforms, including comfort, treatment consistency, and efficiency. It delivers 6.78 MHz monopolar radiofrequency to both the papillary and reticular dermis, producing immediate collagen fiber contraction followed by fibroblast-driven remodeling.
Key features include:
Patient satisfaction reached 81% in a published clinical study of the Volnewmer® platform with significant improvements in skin laxity at 12 weeks and a mean pain score of just 1.94, indicating mild discomfort.
ULTRAFORMER MPT redefines HIFU treatments with next-level precision, speed, and comfort. Powered by Micro-Pulsed Technology (MPT), it delivers rapid, multi-depth lifting and visible results across all skin types.
Key features include:
QUADESSY introduces a next-generation of RF microneedling with technology designed to make treatments faster, more versatile, and more predictable. By synchronizing RF energy across the epidermis, papillary dermis, and reticular dermis in a single pass, it targets tightening, texture, tone, and elasticity while cutting treatment times by more than 50%.
Key features include:
ONDA PRO pairs Italian engineering (manufactured by DEKA) with growing popularity in Korea’s aesthetics market. Its latest-generation Coolwaves® technology uses a 2.45 GHz frequency designed for greater selectivity, combining focused energy delivery with continuous contact cooling to support effective treatment and patient comfort.
Key features include:
Cartessa Aesthetics has become a key channel for bringing differentiated aesthetic technologies from around the world to providers in the U.S. and Canada. Several of the platforms discussed here are available exclusively through Cartessa, giving North American practices access to technologies and treatments helping define the Korean aesthetics trend.
EVERESSE is available exclusively through Cartessa in the U.S. and Canada, while QUADESSY is exclusive to Cartessa in the U.S. ONDA PRO is also available exclusively through Cartessa in both the U.S. and Canada, and ULTRAFORMER MPT is currently available through Cartessa in Canada.
Meeting this demand does not require rebuilding a treatment menu. It requires knowing which of these capabilities your practice already offers and where patient requests are going unanswered.
The opportunity is not simply to add more devices. It is to build a treatment mix that can address a broader range of concerns, from lifting and skin quality to body contouring, while providing more flexibility in how to respond to individual patient goals.
Maintenance-cadence treatments can also turn a single procedure into an ongoing relationship. The more needs a practice can address over time, the easier it becomes to keep that relationship within the practice rather than sending patients elsewhere for treatments it cannot provide.
Global aesthetic trends move quickly, and the technologies behind them don’t always reach North American providers at the same speed. Cartessa Aesthetics closes that gap.
Independent from any manufacturer, Cartessa sources aesthetic medical devices worldwide and vets each one against a three-point standard: better clinical efficacy, an improved patient experience, and achievable ROI. That independence enables the portfolio to span a Korean manufacturer in Classys and an Italian one in DEKA, selected on clinical merit rather than a single supplier relationship.
Additionally, Cartessa’s partnership extends past the purchase. Clinical training, marketing resources, one-on-one practice development, and dedicated service support are built into how Cartessa works with providers, because a device only performs as well as the practice deploying it.
Ready to bring in-demand aesthetic innovation to your practice and build a treatment menu positioned for what patients are asking for next? Connect with the Cartessa team today.